SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-186518
Filing Date
2019-07-01
Accepted
2019-07-01 06:08:34
Documents
5
Period of Report
2019-08-01
Effectiveness Date
2019-07-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d766834ddef14a.htm DEF 14A 655277
2 GRAPHIC g766834g18p88.jpg GRAPHIC 95943
3 GRAPHIC g766834g80a55.jpg GRAPHIC 52118
4 GRAPHIC g766834pc1.jpg GRAPHIC 376138
5 GRAPHIC g766834pc2.jpg GRAPHIC 331900
  Complete submission text file 0001193125-19-186518.txt   1835749
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35670 | Film No.: 19931111
SIC: 2834 Pharmaceutical Preparations